General Disagreements. All disagreements within the Program Management Team and the Steering Committee shall be subject to the following:
(a) The representatives to the Program Management Team or Steering Committee will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute.
(b) In the event that the dispute is not resolved after the period specified in clause (a), the representatives shall promptly present the disagreement to the Chief Executive Officers of Dyax and Genzyme or a designee of such Chief Executive Officer reasonably acceptable to the other Party.
(c) Such executives shall meet or discuss in a telephone or video conference each of Dyax and Genzyme's views and explain the basis for such dispute.
(d) If such executives cannot resolve such disagreement within sixty (60) days after such issue has been referred to them, then such dispute shall be referred to arbitration as described in Section 14.10 hereof.
General Disagreements. All disagreements within the R&D Oversight Committee and the Development Committee shall be resolved in accordance with the provisions of Section 13.6.
General Disagreements. All disagreements within the Research Management Committee shall be subject to the following:
(a) The representatives to the Committee will negotiate in good faith for a period of not more than sixty (60) days to attempt to resolve the dispute;
(b) If the representatives of the Committee are unable to resolve the dispute in accordance with subsection (a) above, then they shall promptly present the disagreement to
General Disagreements. All disagreements within the Program Management Team, the Business and Commercialization Committee and the Steering Committee shall be subject to the following:
(a) If any dispute relates to subject matter for which one of the Parties has primary responsibility pursuant to Section 5.1.4., the Party with such responsibility shall be entitled to unilaterally resolve such dispute, or if such dispute relates to commercialization activities not described in Section 5.1.4 or partnering and licensing activities, Genzyme shall be entitled to unilaterally resolve such dispute.
(b) If such dispute relates to subject matter for which the Parties share joint responsibility pursuant to Section 5.1.4, the representatives to the Program Management Team or Steering Committee will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute.
(c) In the event that the dispute is not resolved after the period specified in clause (b), the representatives shall promptly present the disagreement to the Chief Executive Officer of Genzyme and the President of Aptein, or a designee of such officer reasonably acceptable to the other Party.
(d) Such executives shall meet or discuss in a telephone or video conference each Party’s views and explain the basis for such dispute.
(e) If such executives cannot resolve such disagreement within sixty (60) days after such issue has been referred to them, then such dispute shall be subject to the provisions of Section 15.6 hereof.
General Disagreements. In the event there are disagreements within the Joint Steering Committee, the representatives to the Joint Steering Committee will negotiate in good faith to attempt to resolve the dispute. In the event that the dispute is not resolved, the dispute will be presented to the Chief Executive Officer of GelTex (or a designee) and to the President of Sankyo (or a designee). Such executives shall meet or discuss in a telephone or video conference each of GelTex's and Sankyo's views and explain the basis for such dispute. [ * ]
General Disagreements. 17 6.4. Visit of Facilities..................................... 17 (ii) CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS.
General Disagreements. All disagreements within the Program Management Team or the Steering Committee shall be subject to the following:
(a) The representatives to the Program Management Team or Steering Committee (as the case may be) will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute.
(b) In the event that the dispute is not resolved after the period specified in clause (a), the representatives shall promptly present the disagreement to the Chief Executive Officers of BioMarin and Genzyme or a designee of such Chief Executive Officer reasonably acceptable to the other Party.
(c) Such executives shall meet or discuss in a telephone or video conference each of BioMarin and Genzyme’s views and explain the basis for such dispute.
(d) If such executives cannot resolve such disagreement within thirty (30) days after such issue has been referred to them, then such dispute shall be referred to arbitration as described in Section 14.10 hereof. [**] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
General Disagreements. All disputes of the Steering Committee not --------------------- subject to resolution by Vitex alone shall be subject to the following:
(a) The representatives to the Steering Committee will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute.
(b) In the event that the dispute is not resolved after the period specified in clause (a), the representatives shall promptly present the disagreement to the Chief Executive Officers of Pentose and Vitex or a designee of such Chief Executive Officer reasonably acceptable to the other party.
(c) Such executives shall meet or discuss in a telephone or video conference each of such party's views and explain the basis for such dispute.
(d) If such executives cannot resolve such disagreement within sixty (60) days after such issue has been referred to them, then such dispute shall be referred to arbitration as described in Section 14.5 hereof.
General Disagreements. All disagreements within the Research --------------------- Management Committee shall be subject to the following:
5.3.1.1 The representatives to the Committee will negotiate in good faith for a period of not more than sixty (60) days to attempt to resolve the dispute;
5.3.1.2 If the representatives of the Committee are unable to resolve the dispute in accordance with subsection (a) above, then they shall promptly present the disagreement to the Chief Executive Officer of Shire and the Chief Executive Officer of Cortex;
5.3.1.3 Promptly thereafter, such executives shall discuss each Party's view and explain the basis for such disagreement; and If such executives cannot promptly resolve such disagreement within sixty (60) days after such issue has been referred to them, then such disputes shall be referred to arbitration as described in Section 15.6.
General Disagreements. All disagreements within the Program Management Team or the Steering Committee shall be subject to the following: (a) the representatives to the Program Management Team or Steering Committee, as applicable, will negotiate in good faith for a period of not less than thirty (30) days to attempt to resolve the dispute. In the case of the Program Management Team, any unresolved dispute shall be referred to the Steering Committee for good faith negotiations for an additional period of not less than thirty (30) days to attempt to resolve the dispute; (b) in the event that the dispute is not resolved after the periods specified in clause (a), then such dispute shall be referred to resolution as described in Section 14.10.
